SPOTLIGHT: Analysts: Continued fast growth for vaccine industry


The vaccine market is revving up for a continued expansion over the next few years, according to new analysis by India's RNCOS. Looking at the global market for vaccines from 2007 to 2010, RNCOS says new pediatric vaccines and the "booming" market for influenza drugs in the U.S. and Europe will lead the way to more growth. Between 2003 and 2006 the U.S. vaccines market grew at a rate of 9.3 percent a year and the analysts say the industry will maintain that pace at least through 2008 as more vaccines coming into the market. The growth is occurring as the number of vaccines makers is shrinking. Just a handful of companies dominate the U.S. market. Release

Suggested Articles

The pandemic price could be lowered for larger deals, CEO Stephane Bancel said. Pfizer and BioNTech priced 100M doses at $19.50 each for the U.S.

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Sanofi's cost cuts are adding up, execs said in an update Wednesday. The company has trimmed nearly €1 billion in annual expenses so far in 2020.